Valiant Labs Approves ₹60 Cr Investment in Subsidiary, Director Reappointments
Valiant Laboratories Limited's Board of Directors convened on August 10, 2026, approving several key decisions. The company will invest up to ₹60 Crore in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL), through Optionally Convertible Redeemable Preference Shares. The board also approved the re-appointment of Mr. Santosh Vora as Managing Director for five years and Mrs. Sonal Vira as Independent Director for a second five-year term, both subject to member approval. Additionally, the continuation of Mr. Shantilal Vora's directorship as Non-Executive Non-Independent Director was recommended. The company also plans to shift its registered office and open a new corporate office.
Key Highlights
- Investment of up to ₹60 Cr in wholly-owned subsidiary VASPL approved.
- Re-appointment of MD Mr. Santosh Vora for five years approved.
- Re-appointment of Independent Director Mrs. Sonal Vira for five years approved.
- Registered office to be shifted and new corporate office to be opened.
- Director reappointments are subject to member and regulatory approvals.
Price Impact
More from VALIANTLAB